Home
#InnovateForLife
News
Events
IPHA Forum
IPHA Conference
All other events
Publications
2025
Industry’s Role in Shaping Ireland’s Life Science Strategy
EFPIA Patients Wait Indicator 2024
IPHA Position Paper on Fairer and Faster Access to Medicine
2024
EFPIA Patient WAIT Indicator Survey
Clinical Trials Agreement
Making Ireland a European Leader in Clinical Research
2023
Achieving Universal Access to New Medicines for Irish Patients
Oireachtas briefing
IPHA Policy on Supply Outside Reimbursement Final
IPHA Self-Care Infographic
2022
IPHA reimbursement timelines analysis 2022
Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
IHE Cancer Care Comparator Study
White Paper on Enterprise
2021
Clinical Trials Survey
Cell and Gene Pathfinder Study
IPHA Codes of Practice
Agreement 2021
Pre 2020
BioPharma Ambition
Manifesto for Better Health
Innovation and the IP Framework
Self-Care: Taking Charge of Your Health
Vaccines For Life
Perspectives on Ireland’s Medicines Future
Submissions
2025
IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
IPHA Life Science Strategy Submission Dec 25
IPHA Response LSS Consultation final 25
RD Incentives Consulation_Final 19 May 25
2024
IPHA Submission National Rare Disease Strategy 2024
2023
Expert Taskforce Submission September 2023 letter
Sinn Fein consultation paper Dec 23
Code
Codes of Practice
Transfers of Value
Mandatory notification regarding Advisory Board Meetings
IPHA Code Training
Complaints
Clinical & Regulatory
Regulation for Innovation
Clinical Trials
Medicine Safety
Regulatory Science Ireland
Counterfeit Medicines
Self-Care
About
Members
Board of Directors
Media Queries
Our Team
Affiliates Programme
Job Opportunities
Home
#InnovateForLife
News
Events
IPHA Forum
IPHA Conference
All other events
Publications
2025
Industry’s Role in Shaping Ireland’s Life Science Strategy
EFPIA Patients Wait Indicator 2024
IPHA Position Paper on Fairer and Faster Access to Medicine
2024
EFPIA Patient WAIT Indicator Survey
Clinical Trials Agreement
Making Ireland a European Leader in Clinical Research
2023
Achieving Universal Access to New Medicines for Irish Patients
Oireachtas briefing
IPHA Policy on Supply Outside Reimbursement Final
IPHA Self-Care Infographic
2022
IPHA reimbursement timelines analysis 2022
Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
IHE Cancer Care Comparator Study
White Paper on Enterprise
2021
Clinical Trials Survey
Cell and Gene Pathfinder Study
IPHA Codes of Practice
Agreement 2021
Pre 2020
BioPharma Ambition
Manifesto for Better Health
Innovation and the IP Framework
Self-Care: Taking Charge of Your Health
Vaccines For Life
Perspectives on Ireland’s Medicines Future
Submissions
2025
IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
IPHA Life Science Strategy Submission Dec 25
IPHA Response LSS Consultation final 25
RD Incentives Consulation_Final 19 May 25
2024
IPHA Submission National Rare Disease Strategy 2024
2023
Expert Taskforce Submission September 2023 letter
Sinn Fein consultation paper Dec 23
Code
Codes of Practice
Transfers of Value
Mandatory notification regarding Advisory Board Meetings
IPHA Code Training
Complaints
Clinical & Regulatory
Regulation for Innovation
Clinical Trials
Medicine Safety
Regulatory Science Ireland
Counterfeit Medicines
Self-Care
About
Members
Board of Directors
Media Queries
Our Team
Affiliates Programme
Job Opportunities
Home
About Us
Contact Us
hp events
Home
hp events
